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This section addresses the impact and relevance of the studies described in this 
dissertation. Outlined are the way these studies are relevant to society, which target 
groups can benefit and how research findings have been disseminated. 
Societal relevance 
The acute and long-term consequences of illicit drug use continue to be a matter of global 
concern (EMCDDA, 2015b; UNODC, 2015). Drugs of abuse negatively impact cognitive 
performance and behavior, and increase the risk of developing mental disorders and other 
drug-related problems (EMCDDA, 2015a; Lammers et al., 2014). Likewise, the use of 
alcohol has been linked to substance related problems such as aggressive behavior and 
violence (Beck and Heinz, 2013; Duke et al., 2011). Novel psychoactive substances (NPS) 
that are flooding current drug markets also elicit a high level of public concern (Baumann 
and Volkow, 2015; EMCDDA, 2015b; UNODC, 2015). Life-threatening toxidromes have 
been described for NPS, with symptoms varying from agitation, hallucinations, psychosis, 
violent behaviors to coma. Drug users intoxicated with NPS represent a significant burden 
to healthcare professionals as adverse medical consequences are common. 
One of the aims of this dissertation was to elucidate the effects of alcohol and 
cannabis intoxication on neurocognition and the interaction with marketing and 
aggression exposure. It was shown that exposure to alcohol marketing can activate the 
brain’s reward center and potentially reinforce alcohol use (chapter 2). We have also 
shown that alcohol intoxication is more likely to elicit feelings of aggression (chapter 3). 
Furthermore, we have shown that portrayal of cannabis use also activates the reward 
center and that, other than alcohol, cannabis intoxication decreases feelings of aggression 
(chapter 3). These findings may imply that alcohol or cannabis users, who wish to stay 
abstinent, can be negatively influenced by alcohol and drug marketing, by reinforcing 
alcohol and cannabis use, leading to a vicious cycle of drug-taking behavior. 
Another aim of this thesis was to study the influence of a frequently abused NPS 
(i.e. mephedrone) on neurocognitive function in a placebo-controlled setting. Data from 
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the current NPS study discard the notion that NPS or “legal highs” are safer and milder 
than traditional illegal drugs, and show that NPS effects on neurocognition can be as 
detrimental as those caused by alcohol or traditional drugs of abuse. The distinction 
between “traditional” and “new drugs” is becoming harder to define as NPS are designed 
to mimic the effects of traditional, scheduled drugs of abuse. 
In fact, this was the very first study design ever that obtained medical ethical 
approval for acute administration of a NPS in a phase 1 study. This study was conducted in 
close collaboration with the Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) in 
Barcelona. As such, this study offers a blueprint for future approaches to determine the 
mechanism of action of NPS, their toxicity profiles and pharmacological routes following 
acute administration in a controlled setting. Controlled experimental studies with NPS 
should generally be promoted because these will offer scientific rationales for future 
political and societal responses to challenges posed by NPS (Green and Nutt, 2014). 
Response strategies to the influx and use of NPS often involve drug-scheduling, although 
this approach is not effective and impedes placebo-controlled research with NPS. Ideally, 
clinical pharmacokinetic and pharmacodynamics information in animals and humans 
should be obtained before firm conclusions on the harms of these substances can be 
drawn. NPS research by means of placebo-controlled experimental studies give relevant 
and objective information about their acute effects on neurocognition, which can aid in 
education and prevention messages, as well as therapeutic interventions. This has proven 
to be a challenge in the past since Ethical Review boards often rule that NPS research 
should follow the same guidelines that have been established for the development of 
medicinal products (i.e. Good Manufacturing Process (GMP) requirements). The recent 
ruling of the European Court of Justice that GMP guidelines should not be extended to 
clinical research on substances of abuse that have no clinical usage is therefore is very 
instrumental in promoting further clinical research on acute and long-term effects of NPS 
in humans. 
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Target groups 
The findings discussed in this dissertation are relevant to multiple target groups. Firstly, 
researchers in the field of psychopharmacology can benefit from the information that has 
been added to the existing knowledge on brain mechanisms underlying the reinforcing 
effects of alcohol and drug marketing, and the impact of alcohol and cannabis intoxication 
on different measures of aggression. This thesis also demonstrated that glutamate does 
not play a major role in MDMA-induced memory. This finding supports previous research 
showing MDMA induced impairment is primarily caused by 5-HT2 receptor stimulation 
(van Wel et al., 2011). 
Secondly, the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) and the World Health Organization (WHO) can also benefit from the scientific 
information presented in this dissertation. The data gathered adds to both international 
and European databases and contributes to objective risk estimates concerning illicit drug 
use, which applies to both traditional drugs of abuse as well as NPS. These findings will 
support policymakers in making informed drug policies and strategies, for example 
regarding marketing of alcohol and other drugs of abuse. 
Our findings on the associations between alcohol and aggression also provide 
scientific support for the introduction of a new bill to allow alcohol and drug testing in 
perpetrators of violence, which will come into force in the Netherlands in 2017. The bill 
provides a legal basis for the deployment of alcohol and drug testing in violent offenders. 
The results of these tests can be taken into account in the conviction and sentencing stage 
of the criminal justice process. Our findings support the notion that acute effects of 
alcohol can induce feelings of aggression, provoked as well as unprovoked. Likewise, the 
use of stimulant drugs such as cocaine and amphetamine, have also been associated with 
violence (Hoaken and Stewart, 2003; Lammers et al., 2014; Stoddard et al., 2015; Zhao et 
al., 2015). The study design employed in the current dissertation to measure alcohol-
induced aggression could also be helpful in the development of standardized test batteries 
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to assess drug-induced aggressive behavior in placebo-controlled studies. A standardized 
battery will promote to reliably identify aggression-inducing properties of drugs of abuse. 
Pharmaceutical industries can also benefit from the current findings in the 
development of dopaminergic drug targets that increase tonic dopamine levels to help 
minimize the effects of alcohol and drug marketing by reducing motivation to use drugs. 
Data presented in chapter 2 demonstrates that high tonic levels of dopamine protect 
against the reinforcing potential of alcohol and cannabis marketing. This suggests that 
prescription drugs that increase tonic dopamine levels, such as methylphenidate, may be 
of prophylactic value to alcohol and cannabis abusers to defy alcohol and cannabis 
marketing exposure in our society. Likewise, data presented in chapter 3 may indicate 
novel pharmaceutical indicated for cannabis or cannabinoids. Our finding that cannabis 
reduces feelings of aggression might spark in interest to develop cannabinoid compounds 
to treat people with aggressive personalities. 
Lastly, the current findings are also interesting to the general population and 
(potential) drug users who would like to be informed about the health risks of drug use. 
Different consumption patterns are also associated with different levels and types of 
harm; and more frequent use (i.e., high doses, concurrent use of other substances) are all 
linked to elevated health risks. 
Dissemination and impact 
One of the goals of researchers in the field of psychopharmacology and addiction is to 
assess the acute and long-term effects of psychoactive substances on neurocognition and 
mood, and identify factors that make people more susceptible to addictions. The ultimate 
goal being the translation of experimental findings into practical applications aimed at 
reducing health risks associated with drug exposure by helping people stay in control of 
their own behavior. We have taken various efforts to ensure that the knowledge gained 
from our studies is spread across different target groups. Four out of five studies 
described in this dissertation have been published in several international journals to 
spread the findings to the international research community. In addition, most results 
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have been presented at national and international conferences that hosted many 
researchers from across the globe. The study in chapter 2 was part of the ‘Addictions and 
Lifestyles In Contemporary Europe Reframing Addiction Project (ALICE RAP)’ initiated by 
the European Commission. ALICE RAP was aimed to stimulate a broad and productive 
debate on science-based policy approaches to addictions. The findings of chapter 2 have 
been published on the website of ALICE RAP (http://www.alicerap.eu/) and were 
discussed during a scientific debate, ‘the A debate’. The A-debate was an interactive 
discussion of addiction science (on-site and on-line) featuring scientists, policy actors from 
national and international organizations and clinical professionals, with the objective of 
presenting and discussing key research findings that came out of the project. 
The findings of chapter 3 have also been covered by highly influential 
newspapers, such as the ‘Washington Post’, the ‘Portland Press Herald’ and ‘De Morgen’. 
This ensured dissemination of the research findings to the general public and science 
communicators. In September 2016, 2 month after publication, the findings in chapter 3 
were mentioned by 11 news outlets, 127 tweeters and 19 Facebook pages, which led to a 
high Altmetric score of 199 (i.e. in top 5% of all research outputs scored by Altmetric). 
Finally, the studies were given more international attention by making most of 
these publications Open Access. Our future goal is to continue disseminating our research 
findings by means of (inter)national journal publications, (inter)national conference visits 
and through websites. In addition, the communication of research findings by means of 
workshops and public debates in order to provide a more interactive atmosphere will 
keep the scientific community as well as the general public informed. 
 
